<p>(A&B) Immunohistochemical study detecting HMGB1 in the CA1 (A) and CA3 (B) hippocampal regions from the NS group mice (<i>n</i> = 5). HMGB1 immunoreactivity was detected mostly in the nuclei of the pyramidal neurons. (C&D) Immunohistochemical study detecting HMGB1 in the CA1 (C) and CA3 (D) hippocampal regions from the EP group mice (<i>n</i> = 6). Cytoplasmic staining of HMGB1 was substantially increased in the pyramidal neurons compared with the NS group. Glial cells with both nuclear and cytoplasmic staining were also found. Scale bar: 50 μm. Red arrows: neurons with nuclear staining; Blue arrows: glial cells with nuclear staining; Red arrowheads: neurons with both nuclear and cytoplasmic staining; Blue arrowheads: glial cells with bo...
High mobility group proteins are chromatin binding factors with key roles in maintenance of nuclear ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Approximately 30% of epilepsy patients experience seizures that are not controlled by the available ...
<p>(A) Immunohistochemical staining of P-gp in CA1 hippocampal areas of each group mice (NS group, <...
Background/Aims: Neuroinflammatory processes have been implicated in the pathophysiology of seizure/...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Abstract Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable ne...
The High Mobility Group Box 1 (HMGB1) is the most abundant nuclear nonhistone protein that is involv...
The multifunctional protein high mobility group box 1 (HMGB1) is expressed in hippocampus and cerebe...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
High mobility group box-1 (HMGB1) is a non-histone, DNA-binding nuclear protein belonging to the fam...
Epilepsy is a serious neurological condition exhibiting complex pathology and deserving of more seri...
<p>Representative confocal merger images showing A: double immunofluorescent staining with anti-HMGB...
<p>A-F. Double-labeling immunohistochemistry for HMGB-1 and NeuN (A, B, a marker for neurons), GFAP ...
High mobility group proteins are chromatin binding factors with key roles in maintenance of nuclear ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Approximately 30% of epilepsy patients experience seizures that are not controlled by the available ...
<p>(A) Immunohistochemical staining of P-gp in CA1 hippocampal areas of each group mice (NS group, <...
Background/Aims: Neuroinflammatory processes have been implicated in the pathophysiology of seizure/...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Abstract Epilepsy is a common neurological disease caused by synchronous firing of hyperexcitable ne...
The High Mobility Group Box 1 (HMGB1) is the most abundant nuclear nonhistone protein that is involv...
The multifunctional protein high mobility group box 1 (HMGB1) is expressed in hippocampus and cerebe...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
High mobility group box-1 (HMGB1) is a non-histone, DNA-binding nuclear protein belonging to the fam...
Epilepsy is a serious neurological condition exhibiting complex pathology and deserving of more seri...
<p>Representative confocal merger images showing A: double immunofluorescent staining with anti-HMGB...
<p>A-F. Double-labeling immunohistochemistry for HMGB-1 and NeuN (A, B, a marker for neurons), GFAP ...
High mobility group proteins are chromatin binding factors with key roles in maintenance of nuclear ...
The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) ...
Approximately 30% of epilepsy patients experience seizures that are not controlled by the available ...